UNSPSC 51313002: Talastine

This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49AB2PA48B. European Medicines Agency schedules Talastine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10801MIG. Talastine generally arises in the molecular formula C19H21N3O.

UNSPSC 51313002 Talastine, a Commodity code, describes naloxone and drug deactivation systems that state and local governments procure as part of community health and emergency response initiatives. The work involves supplying pharmaceutical countermeasures and related systems to support public health agencies' opioid-response and harm-reduction programs. Issuing bodies include county health departments and public safety agencies.

Seminole County, Florida solicited this commodity through an IFB (Invitation for Bid) in mid-2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The IFB required vendors to submit bids electronically by July 26, 2023, include all shipping and delivery costs in proposals, provide unit pricing for each line item, and comply with drug-free workplace certification and E-Verify requirements. The initial contract term was two years with an optional one-year renewal. The source shows activity limited to a single Florida county opportunity posted in mid-2023; no other state or local jurisdictions appear in the recent opportunities block, and no current or future procurement activity is indicated.